DOCSLIB.ORG

Supplementary Data

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

SUPPLEMENTARY DATA The Japan Diabetes Complications Study (JDCS) Group Primary Investigators: Hirohito Sone, Nobuhio Yamada (University of Tsukuba); Chief in Assessment Committee: Yasuo Akanuma (Institute for Adult Diseases Asahi Life Foundation); Keita Ato, Masaaki Eto, Hiroshi Ito (Asahikawa Medical College), Naotake Hashimoto, Azuma Kanatsuka, Yasushi Saito, Kenichi Sakurai, Kazuo Takahashi, Kazuo Yagi, Kotaro Yokote (Chiba University), Tadami Takekoshi, Takanobu Wakasugi (Fukui Prefectural Hospital), Shigetake Toyooka (Fukui Red Cross Hospital), Yukihiro Bando (Fukui Saiseikai Hospital), Tsugihiko Nakai, Koji Oida, Jinya Suzuki (Fukui University), Yasuaki Fukumoto, Seiichi Sumi (Garatia Hostiptal), Tomokazu Awaya, Genshi Egusa, Rumi Fujikawa, Masamichi Okubo, Kiminori Yamane (Hiroshima University), Takao Koike, Narihito Yoshioka (Hokkaido University), Yasuo Akanuma, Motonobu Anai, Ritsuko Honda, Shoji Kawatsu, Masatoshi Kikuchi (Institute for Adult Diseases Asahi Life Foundation), Shun Ishibashi (Jichi Medical School), Masanobu Kawakami, Kazuyuki Namai, Hiroyuki Tamemoto, Hideo Toyoshima (Jichi Medical School Saitama Medical Center), Masami Nemoto, Takashi Sasaki (Jikei University),Ryuzo Kawamori, Yasushi Tanaka (Juntendo University), Toshihiko Ishida (Kagawa University), Toshihide Kawai, Izumi Takei (Keio University), Yoshikuni Fujita, Keiji Tanaka, Yoshihiro Yajima (Kitazato University), Noboru Furukawa, Hideki Kishikawa, Tetsushi Toyonaga, Kaku Tsuruzoe (Kumamoto University), Yoichi Imamura, Shingo Komichi, Zenji Makita, Kyohei Nonaka, Kentaro Yamada (Kurume University), Naoto Nakamura, Koji Nakano (Kyoto Prefectural University of Medicine), Toyoshi Iguchi, Hajime Nawata (Kyushu University), Yasuhisa Matsushima (Matsudo City Hospital), Hideo Takahashi (Minami Akatsuka Clinic), Hiroyuki Toyoshima (Minoh City Hospital), Shoichi Akazawa, Eiji Kawasaki, Shigenobu Nagataki (Nagasaki University), Toshio Hayashi, Nigishi Hotta, Jiro Nakamura (Nagoya University), Kentaro Doi, Yu Harano, Hisashi Makino, Yasunao Yoshimasa (National Cardiovascular Center), Yoichi Hayashi (Nihon University), Shinnichi Oikawa (Nippon Medical School), Ryuzou Abe (Ohta Memorial Hospital),Hiroaki Seino, Susumu Suzuki, Daishiro Yamada (Ohta-Nishinouchi Hospital), Mitsuru Hoshi, Eiichi Imano, Takao Watarai (Osaka Koseinenkin Hospital), Masatoshi Imaizumi, Hideki Taki, Ryuhei Todo (Osaka National Hospital), Keisuke Kosugi, Yasuhisa Shimizu, Yutaka Umayahara (Osaka Police Hospital), Munehide Matsuhisa, Junichiro Miyagawa, Mitsuyoshi Nanba, Kohei Okita, Kaoru Takemura, Yoshimitsu Yamasaki (Osaka University), Yoshihito Atsumi, Kazuhiro Hosokawa, Kempei Matsuoka (Saiseikai Central Hospital), Junko Nakano, Hirotaka Umezu (Saiseikai Fukushima General Hospital), Akihiko Hoshino, Toshihiko Nishiyama, Tetsushi Nogami (Saisekai Kumamoto Hospital), Hideo Nunome (Saiseikai Mito Hospital), Shigehiro Katayama, Susumu Kurihara, Atsuhito Togashi (Saitama Medical College), Kenichi Yamada (Sakura National Hospital), Shinichi Araki, Atsunori Kashiwagi, Yoshihiko Nishio (Shiga University of Medical Science), Yukio Yoshimura (Shikoku University), Tatsuhide Inoue (Shizuoka General Hospital), Masafumi Kitaoka (Showa General Hospital), Toshio Kitada, Akio Shirai, Ryoichiro Watanabe (Takeda General Hospital), Takaichi Miyagawa (Tama Minami Clinic), Osamu Mokuta, Ryo Okazaki, Yoshikazu Sakamoto (Teikyo Universiy Ichihara Hospital), Yasushi Ishigaki, Kazuma Takahashi (Tohoku University),Yoh Miyashita, Koji Shirai (Toho University Sakura Hospital), Akira Tanaka (Tokyo Medical and Dental University), Yoshiaki Fujita (Tokyo Metropolitan Institute of Gerontology), Hideki Ito (Tokyo Metroporitan Geriatric Hospital) Yasuhiko Iwamoto, Reiko Kawahara, Yasue Omori, Asako Sato (Tokyo Women’s Medical University), Yasumichi Mori, Toshio Murase, Mitsuhiko Noda, Masato Odawara (Toranomon Hospital),Masashi Kobayashi, Masaharu Urakaze (Toyama University), Rei Aida, Hitomi Fujii, Satoshi Iimuro, Takashi Kadowaki, Yasuo Ohashi, Junichi Osuga, Yasuyoshi Ouchi, Akane Takahashi, Sachiko Tanaka, Shiro Tanaka (University of Tokyo), Hirohito Sone, Nobuhiro Yamada, Kamejiro Yamashita (University of Tsukuba), Ryo Kawasaki, Hidetoshi Yamashita (Yamagata University), Hisahiko Sekihara, Yasuo Terauchi (Yokohama City University), Tetsuo Nishikawa (Yokohama Rosai Hospital), Hiroto Furuta, Kishio Nanjo (Wakayama Medical University) ©2013 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0654/-/DC1 SUPPLEMENTARY DATA Supplementary Table 1. Summary of cohort studies of total dietary fibre and stroke in the literature. Prevalence of Incidence rate Men Women per 1000 person- Total dietary Study population diabetes HR (95% CI) Total dietary fibre* HR (95% CI) years fibre* Ascherio et al. 199814 0% 1.01 12.4 Ref – – 0.85 (0.61– 43738 men 328 strokes 16.6 – – 1.19) 323394 person- 0.85 (0.61– USA 19.7 – – years 1.19) 0.65 (0.45– 23 – – 0.93) 0.70 (0.48– 28.9 – – 1.00) Oh et al. 200515 0% 0.72 – – 10 Ref 0.97 (0.79– 78779 women 1020 strokes – – 12.8 1.19) 1418022 person- 0.89 (0.71– USA – – 14.9 years 1.10) 0.86 (0.69– – – 17.1 1.07) 0.83 (0.66– – – 21 1.04) Larsson et al. 200916 4.9 to 7.6% 9.34 16.1 Ref – – 1.01 (0.82– 26556 male smokers 3365 strokes 20.9 – – 1.25) 360187 person- 1.05 (0.87– Finland 24.7 – – years 1.25) 0.96 (0.84– 28.9 – – 1.09) 1.00 (0.86– 35.8 – – 1.17) Eshak et al. 201017 3 to 7% 1.32 <7.8 Ref <8.5 Ref 23119 men and 35611 1.14 (0.74– 0.78 (0.55– 983 strokes 7.8–9.4 8.5–9.9 women 1.76) 1.12) 743167 person- 1.12 (0.74– 1.08 (0.76– Japan 9.5–10.8 10.0–11.1 years 1.69) 1.54) 1.15 (0.70– 0.89 (0.61– 10.9–12.6 11.2–12.7 1.56) 1.30) >12.6 1.09 (0.75– >12.7 1.05 (0.73– ©2013 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0654/-/DC1 SUPPLEMENTARY DATA 1.58) 1.51) Kokubo et al. 201118 2 to 9% 2.84 6 Ref 7.8 Ref 40046 men and 46341 0.94 (0.78– 0.89 (0.71– 2553 strokes 9.8 11.8 women 1.14) 1.11) 899141 person- 0.89 (0.71– 0.85 (0.67– Japan 11.7 13.7 years 1.11) 1.08) 0.92 (0.73– 0.73 (0.55– 14 15.9 1.17) 0.95) 1.00 (0.76– 0.64 (0.46– 19.9 21.6 1.32) 0.88) Wallstrom et al. 201219 0% 2.71 5.8 Ref 6.5 Ref 8139 men and 12535 755 ischaemic 0.87 (0.64– 0.70 (0.50– 7.1 8.1 women strokes 1.17) 0.98) 279099 person- 0.86 (0.63– 0.88 (0.64– Sweden 8.2 9.3 years 1.16) 1.21) 0.86 (0.63– 0.77 (0.55– 9.3 10.6 1.17) 1.08) 0.69 (0.49– 0.73 (0.52– 11.4 12.9 0.96) 1.04) HR: hazard ratio, CI: confidence interval *Means in quintiles for Kokubo et al., medians in quintiles for others ©2013 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0654/-/DC1 SUPPLEMENTARY DATA Supplementary Table 2. Cox regression analysis of incidence of cerebral infarction* and intake of total, soluble and insoluble dietary fibre and vegetables and fruits. Quartile analysis Linear analysis Q2 Q3 Q4 HR per Q1 HR 95%CI p HR 95%CI p HR 95%CI p 1g increase 95%CI p Total dietary fibre, mean±SD 8.7±1.6 12.5±0.9 15.8±1.0 21.8±4.0 Age and sex adjusted Ref 0.56 (0.27–1.17) 0.12 0.56 (0.27–1.19) 0.13 0.63 (0.31–1.28) 0.21 0.95 (0.90–1.00) 0.07 Adjusted for risk factors† Ref 0.41 (0.17–0.96) 0.04 0.45 (0.18–1.12) 0.08 0.46 (0.14–1.53) 0.20 0.85 (0.76–0.95) 0.01 Further adjusted for energy‡ Ref 0.41 (0.17–0.98) 0.05 0.45 (0.17–1.17) 0.10 0.46 (0.12–1.68) 0.24 0.83 (0.73–0.94) <0.01 Soluble dietary fibre, mean±SD 2.1±0.4 2.9±0.2 3.7±0.3 5.1±1.2 Age and sex adjusted Ref 0.61 (0.30–1.23) 0.16 0.53 (0.24–1.14) 0.11 0.53 (0.26–1.08) 0.08 0.79 (0.62–1.00) 0.05 Adjusted for risk factors* Ref 0.48 (0.21–1.09) 0.08 0.39 (0.15–1.00) 0.05 0.37 (0.11–1.21) 0.10 0.54 (0.33–0.88) 0.01 Further adjusted for energy† Ref 0.47 (0.20–1.09) 0.08 0.38 (0.14–1.03) 0.06 0.36 (0.10–1.28) 0.11 0.49 (0.28–0.85) 0.01 Insoluble dietary fibre, mean±SD 6.3±1.2 9.0±0.7 11.4±0.9 15.8±2.9 Age and sex adjusted Ref 0.62 (0.30–1.28) 0.20 0.58 (0.27–1.23) 0.15 0.67 (0.33–1.37) 0.27 0.94 (0.87–1.01) 0.08 Adjusted for risk factors† Ref 0.54 (0.24–1.23) 0.14 0.42 (0.16–1.08) 0.07 0.50 (0.15–1.66) 0.26 0.82 (0.70–0.96) 0.01 Further adjusted for energy‡ Ref 0.54 (0.24–1.26) 0.15 0.42 (0.16–1.13) 0.09 0.51 (0.14–1.83) 0.30 0.80 (0.67–0.95) 0.01 Vegetables and fruits, mean±SD 228.7±84.0 371.9±83.0 499.0±93.8 721.4±197.3 Age and sex adjusted Ref 1.07 (0.54–2.10) 0.85 0.69 (0.32–1.51) 0.35 0.57 (0.25–1.27) 0.17 0.999 (0.997–1.000) 0.04 Adjusted for risk factors† Ref 0.96 (0.45–2.06) 0.91 0.59 (0.23–1.49) 0.27 0.40 (0.13–1.22) 0.11 0.997 (0.995–0.999) 0.01 Further adjusted for energy‡ Ref 0.97 (0.45–2.08) 0.93 0.60 (0.24–1.52) 0.28 0.41 (0.13–1.26) 0.12 0.997 (0.995–0.999) 0.01 HR: hazard ratio, CI: confidence interval ©2013 American Diabetes Association.
Recommended publications
  • September 2010 BUDDHIST CHURCH of OAKLAND

    September 2010 BUDDHIST CHURCH of OAKLAND

    BUSSHIN SEPTEMBER 2010 BUDDHIST CHURCH OF OAKLAND BUSSHIN september 2010 Volume 53 Number 9 Looking Back, Thinking Ahead, Living Now BY REVEREND HARRY GYOKYO BRIDGE IN THIS ISSUE o much of our lives are con- look back fondly on the past, Snected to the seasons. Our perhaps wishing it could be that Minister’s Message 1 school calendar is set up so that way again. I don’t think that this President’s Musings 2 children can participate in the sum- is necessarily a bad thing, as long mer harvest. We associate many of as we don’t get too caught up Temple Tidbits 2 our holidays, such as Thanksgiving in it, attached to the way things or the Fourth of July, with certain were. Similarly, we often wonder In Memoriam 2 times of year. In fact, many “reli- how the future will turn out. Of gious” holidays, such as Christmas course, we should consider the Mrs. Kayoko Fujimoto 4 or Easter, were originally celebra- future and the effects of our ac- tions of special times of year, the tions, but at the same time, we Bingo Volunteers Needed 6 equinoxes and solstices. shouldn’t worry too much about Nippongo Gakuen 6 Fall Ohigan is one of those how things might be. times. The days have gradually Perhaps this is part of what Nippongo Gakuen Registration 7 been getting shorter – Ohigan Ohigan teaches us – to try and marks the time when day and achieve balance in our lives. I Newsroom OBWA 8 night become equal. And soon the know that this is not a traditional days will get even shorter! This is approach to Ohigan, but I really Momiji Kai News 8 my favorite time of year.
  • Chapter 4： Science and Technology Supported by Society and the Public

    Chapter 4： Science and Technology Supported by Society and the Public

    Keyword: Part 2 - Measures Implemented to Promote Science and Technology Science and Technology Supported by Society and the Chapter 4 Chapter 4 Pubic 1 Responsible Approaches to Ethical, Legal, and Social Issues in Science and Technology (1) Establishing of a sense of ethics for researchers and engineers In recent years, Japan has faced a situation where misconduct, such as fabrication, falsification, or plagiarism (FFP) of data in research, has been revealed. Such misconduct in scientific research must not be allowed since it goes against the essential qualities of science to create new knowledge through accumulated searches for truth. Misconduct also undermines public trust in science and hinders scientific progress. Following the approval of the Proper Counteractions against Research Misconduct by CSTP in February 2006, CSTP revised the Countermeasures against Misconduct in Research Activities by the Competitive Research Fund (agreement in the Liaison Committee of Ministries and Agencies Concerned with Competitive Funding) in November 2006 to stipulate measures for FFP in research. Thereafter, the establishment of guidelines, reflection in application guidelines, and other measures were promoted among the related ministries and agencies. MEXT established a special committee on research misconduct under CST. In August 2006, the committee finalized guidelines on the systems and rules to be formulated by MEXT, funding agencies, and other research organizations such as universities. The guidelines requested them to implement approaches to misconduct, including establishment of a reception desk for accusations, investigation systems, and formulation of provisions related to the above-stated issues; MEXT established a reception desk for accusations within the ministry in November 2006. In December 2006, MAFF also finalized such guidelines on actions for misconduct in research, requested related organizations to implement approaches to misconduct, and established a reception desk for accusations.
  • ESJ67 Program Web.Pdf

    ESJ67 Program Web.Pdf

    CONTENTS 㣐⠓傈玎嚊殛.FFUJOH4DIFEVMF 㣐⠓傈玎♧鋮邌 5JNFUBCMF 长周ⰻ٥岣䠐✲갪٥傈劤欰䡾㷕⠓㣐⠓鋉⵱ (FOFSBMJOTUSVDUJPOT /PUJDFTGPSQBSUJDJQBOUT #ZMBXTGPSUIF"OOVBM.FFUJOHTPGUIF&DPMPHJDBM4PDJFUZPG+BQBO NBQTBOENBJOWFOVF 㜥周ⰻ"DDFTT⠓٥㖑㔳٥أإؙ، -FDUVSFTCZBXBSESFDJQJFOUT 颣鎸䙀闌怴"XBSEDFSFNPOZ」㷕⠓颣ぐ颣䱇颣䒭٥ ⰕꟚ闌怴⠓1VCMJDMFDUVSFT ׮欰䡾㷕闌䏟ו欰䡾㷕闌䏟պ٥ֿ،صُآךז٦涪邌⠓չ׫׿ةأه넝吤欰 1PTUFSQSFTFOUBUJPOTCZIJHITDIPPMTUVEFOUT &DPMPHZDPVSTFGPSIJHITDIPPMTUVEFOUT &DPMPHZDPVSTFGPSDIJMESFO 嚊銲4ZNQPTJVNTيؐآهٝء 荈歋꧊⠓嚊銲8PSLTIPQT 嚊銲'PSVNTيؿؓ٦ٓ 〡걧涪邌♧鋮 0SBMQSFTFOUBUJPOT ٦涪邌♧鋮ةأه 1PTUFSQSFTFOUBUJPOT ٦涪邌♧鋮ةأه넝吤欰 1PTUFSQSFTFOUBUJPOTCZIJHITDIPPMTUVEFOUT 歗罏♧鋮1SFTFOUFSTBOE0SHBOJ[FST*OEFY⟰涪邌罏٥ "EWFSUJTFNFOU 额♧鋮٥䎢デ4QPOTPST⼿ 周ⰻ׀ך痥㔐傈劤欰䡾㷕⠓㣐⠓䎃剢٥䀤㿊 *NGPSNBUJPOPGUIFUI"OOVBM.FFUJOHPG&4+ JO0LBZBNB ٥㣐⠓㹋遤㨻㆞⠓せ砢$PNNJUUFFT⠓㣐⠓⟰歗㨻㆞ ׅկת鋮ְ׋׌ֽ׀דآ٦لي٦م⠓㣐כ姻铎邌ךيؚٓٗف 5IFFSSBUBPGUIFQSPHSBNBSFEJTDMPTFEJOUIF&4+XFCTJUF 㷕⠓ꞿ⽑鿇㙹㣕龤 㣐⠓⠓ꞿ傈ꅿ鰛僇խ 㣐⠓㹋遤㨻㆞ꞿ堀劤㉔〷խ㣐⠓⟰歗㨻㆞ꞿⰻ嵲⤥➜ 宓宵宨家宬宧宨宱宷季孲季宍宲宷室宵宲季官宕宄宅守 宆宫室宬宵季宲宩季宒宵宪室宱宬宽宬宱宪季宆宲宰宰宬宷宷宨宨季孲季宗宨宵宸室宮宬季宋完宑宒 宖宨宦宵宨宷室宵宼季宊宨宱宨宵室宯季宲宩季宒宵宪室宱宬宽宬宱宪季宆宲宰宰宬宷宷宨宨季孲季宋宬宵宲家宫宬季宋宄宖宋完宐宒宗宒 宆宫室宬宵季宲宩季宄宱宱宸室宯季宐宨宨宷宬宱宪季宓宯室宱宬宱宪季宆宲宰宰宬宷宷宨宨季孲季宖宫宸宱家宸宮宨季官宗宖官宐完 㣐⠓傈玎嚊殛.FFUJOH4DIFEVMF Ӫぐ珏㨻㆞⠓$PNNJUUFFNFFUJOHT 宏8FE 㣐⠓⟰歗㨻㆞⠓3PPN) 㢩勻珏㉏겗嗚鎢⡲噟鿇⠓3PPN* 欰䡾禸盖椚㼔Ꟍ㨻㆞⠓3PPN+ 㼛勻鎘歗㼔Ꟍ㨻㆞⠓3PPN& 荈搫⥂隊㼔Ꟍ㨻㆞⠓3PPN' ⥂Ⰻ欰䡾㷕灇瑔ⴚ遤⼿陽⠓3PPN) ٍؗٔ،佄䴂㼔Ꟍ㨻㆞⠓3PPN* ꅿ㢩㸜Ⰻ盖椚㨻㆞⠓3PPN+ &DPMPHJDBM3FTFBSDIⴚ遤⼿陽⠓3PPN' 傈劤欰䡾㷕⠓钞ⴚ遤⼿陽⠓3PPN) 欰䡾㷕侄肪㼔Ꟍ㨻㆞⠓3PPN* 㣐鋉垷ꞿ劍欰䡾㷕㼔Ꟍ㨻㆞⠓3PPN+ ➿陽㆞⠓3PPN# Ӫ筨⠓䱇颣䒭「颣闌怴(FOFSBMNFFUJOH "XBSEDFSFNPOZ -FDUVSFTCZBXBSESFDJQJFOUT 㕼4BU Room A / ˊ 筨⠓(FOFSBMNFFUJOH FDUVSFTCZBXBSESFDJQJFOUT-颣鎸䙀闌怴"XBSEDFSFNPOZ٥」䱇颣䒭٥ ˊ &3锷俑颣薉铂〡걧涪邌颣⸆⸤颣㤺⸠ ꈿ加 颣 խխ ˊ 㣐䃊颣㹧㖑颣欰䡾㷕⠓颣 ♧菙闌怴ي٥ؿؓ٦ٓ⠓荈歋꧊يؐآهٝءӪ
  • Mitsubishi Estate Corporate Data (PDF 65KB)

    Mitsubishi Estate Corporate Data (PDF 65KB)

    MITSUBISHI ESTATE CORPORATE DATA Directors and Corporate Information Statutory Auditors Chairman of the Board Head Office: Takeshi Fukuzawa Otemachi Building, 6-1, Otemachi 1-chome, Chiyoda-ku, Tokyo 100-8133, Japan President and Chief Executive Officer Web site: http://www.mec.co.jp Shigeru Takagi* Phone: (03) 3287-5100 Director/Deputy President Date of Establishment: Eiji Tan* May 7, 1937 Directors/Executive Vice Presidents Paid-in Capital: Takayuki Hara ¥86,534 million Yasuhiko Watanabe* Atsushi Morimoto* Number of Shares of Common Stock Issued: Terutake Miyamoto* 1,299,185,054 shares Kazuo Odagawa Number of Shareholders: Hiroharu Koinuma 83,566 (excluding shareholders with less than 1,000 shares) Keiji Kimura* Major Shareholders: % of total Senior Executive Officers The Master Trust Bank of Japan, Ltd. (Trust Account) 5.79 Satoshi Oyama Japan Trustee Services Bank, Ltd. (Trust Account) 5.42 Yasuto Suzuki State Street Bank and Trust Company 5.01 Takaya Endo Meiji Yasuda Life Insurance Company 4.46 Seiichiro Suzuki The Bank of Tokyo-Mitsubishi, Limited 3.36 Nobuyuki Iizuka The Tokio Marine and Fire Insurance Co., Ltd. 3.15 Toshio Nagashima The Chase Manhattan Bank, N.A. London, S.L. Omnibus Account 3.15 Mitsuo Iwai Taisei Corporation 2.26 Executive Officers Mellon Bank Treaty Clients Omnibus 2.21 Toshihide Yoshimura Takenaka Corporation 2.19 Toyohisa Miyauchi Major Consolidated Subsidiaries: Masaaki Kono Mitsubishi Jisho Sekkei Inc. Hiroshi Danno Mitsubishi Real Estate Services Co., Ltd. Kazuo Takahashi Mitsubishi Estate Home Co., Ltd. Yuzuru Shibagaki Yokohama Royal Park Hotel Co., Ltd. Takao Yagihashi Aqua City Co., Ltd. Hiroyoshi Ito Marunouchi Heat Supply Co., Ltd.
  • Wrestling Observer Newsletter February 17, 1992

    Wrestling Observer Newsletter February 17, 1992

    Wrestling Observer Newsletter February 17, 1992 Just days after the Florida state legislature voted down the bill licensed with the commission so that their names would be on to implement steroid testing of pro wrestlers, World file for the random anabolic steroid and street drug tests, Championship Wrestling Executive Vice President Kip Frey however there would be no licensing or registration fee announced the promotion would be announcing an anti-steroid policy within the next week. No details about the policy were *Promoters would be charged an annual fee for a promoter's available at press time but it will include wrestlers making public license. If the promoter averaged more than 1,000 paying service anti-steroid promos on television. Hopefully Frey, who is spectators per event in Florida over the previous year, his a newcomer to the wrestling world, will realize the touchiness license fee would be $1,000 (which would mean only WWF and involved in this issue and not try to have wrestlers who have WCW). All others wishing to promote would have to pay $250 achieved the spotlight partially through the use of steroids for a promoters license (which covers a lot of ground) to then make statements that give one the impression they would never touch the stuff. Frey *There would be a five percent tax on all live gates. The original also said in comments for this coming Sunday's Miami Herald bill included taxes not only on live gates, but also on gimmicks that WCW would be instituting a policy to post signs in front of sold at live events and pay-per-view revenue from systems arenas when advertised talent isn't going to appear.
  • PREPARE YOUR CONGRESS Advance Programme

    PREPARE YOUR CONGRESS Advance Programme

    HELP SHAPE THE FUTURE OF RESPIRATORY SCIENCE AND MEDICINE PREPARE YOUR CONGRESS Advance Programme TAKE PART IN ERS LONDON 2016 ERSCONGRESS. ORG PROGRAMME AT A GLANCE REGISTRATION FEES Early bird (until 12 Standard (13 July to Onsite (from 3 July 2016) 2 September 2016) September 2016) Postgraduate courses € 95 € 125 € 140 Full day postgraduate course € 155 € 200 € 220 Challenging clinical cases € 70 € 90 € 100 Meet the expert € 70 € 90 € 100 Educational skills workshops € 70 € 90 € 100 Professional development € 25 € 35 € 40 worshops ERS International Congress 2016 OUTLINE PROGRAMME SATURDAY 03 SEPTEMBER, 2016 SATURDAY 03 SEPTEMBER 2016 EPIDEMIOLOGY/ START END TYPE SESSION TAG IMPORTANT INFORMATION ENVIRONMENT 08:00 10:20 Skills workshop SW1 Inhaler techniques Clinical Registration for this session is additional to the congress registration fee and is €100 on site, €90 INFECTION standard or €70 for early bird registration. INTENSIVE CARE 10:40 13:00 Skills workshop SW2 Inhaler techniques Clinical Registration for this session is additional to the congress registration fee and is €100 on site, €90 ONCOLOGY standard or €70 for early bird registration. PAEDIATRIC 14:30 16:50 Skills workshop SW3 Inhaler techniques Clinical Registration for this session is additional to the congress registration fee and is €100 on site, €90 PHYSIOLOGY standard or €70 for early bird registration. 09:30 17:30 Postgraduate PG1 Asthma and chronic Clinical Registration for this session is additional to the SLEEP Course obstructive pulmonary disease Translational congress registration fee and is €220 on site, €200 standard or €155 for early bird registration. An update in assessment and INDUSTRY treatment 09:30 17:30 Postgraduate PG2 Advanced thoracic Clinical Registration for this session is additional to the Course ultrasound congress registration fee and is €220 on site, Enhance your sonography €200 standard or €155 for early bird registration.

  • Oral Program, September 29 (Fri) 2017 Plenary Session Noyori Conference Hall Presentation Time Title, Author(S) No

    Oral Program, September 29 (Fri) 2017 Plenary Session Noyori Conference Hall Presentation Time Title, Author(s) No. 14:30- Opening Ceremony 14:40 Chair: N. Ikarashi 14:40- 29-0-1 Blue LEDs and Transformative Electronics for Establishing Sustainable Smart Society 15:40 (Invited) Hiroshi Amano (Nagoya University, Japan) 15:40- 16:00 Chair: T. Uchiyama CU TIP Innovation: Education Program for Innovator and Research Development for Social and Business 16:00- 29-0-2 Application 17:00 (Invited) Chavalit Ratanatamskul (Chulalongkorn University, Thailand) 17:00- 17:15 17:15- Welcome Reception 19:15 8 Oral Program, September 30 (Sat) 2017 Session 1 Room014 Nano-Carbon and related materials and thin films Presentation Time Title, Author(s) No. Chair: M. Kusunoki 30-1-1 13:00- Transition metal dichalcogenides based van der Waals heterostacks: fabrication and properties (1361) 13:30 Ryo Kitaura (Nagoya Univ.) (Invite) Chair: A. Endo 13:30- 30-1-2 Two-Step Excitation in Monolayer Graphene Induced by Near-Infrared Pulse 13:45 (1238) T. Koyama, K. Mizutani (Nagoya Univ.), H. Ago (Kyushu Univ.) and H. Kishida (Nagoya Univ.) Interface engineering of graphene on SiC 13:45- 30-1-3 Wataru Norimatsu (Nagoay Univ.), Jianfeng Bao (Inner Mongolia Univ. for Nationalities), Takahiro Ito 14:00 (1236) and Michiko Kusunoki (Nagoay Univ.) Chair: T. Koyama Characterization of Epitaxial Graphene Layers on SiC Substrate by Low-temperature 14:00- 30-1-4 Magnetotransport Measurements 14:15 (1241) Akira Endo (Univ. of Tokyo), Jianfeng Bao (Nagoya Univ.) (Inner Mongolia Univ. for Nationalities), Keita Matsuda, Wataru Norimatsu and Michiko Kusunoki (Nagoya Univ.) Thermal Stability Study of in-situ Sb-Doped n- Ge1-xSnx Epitaxial Layers for Source/Drain Stressor 14:15- 30-1-5 of Strained Ge Transistors 14:30 (1227) J.

  • Algorithm of the JJ Risk Engine

    SUPPLEMENTARY DATA Algorithm of the JJ risk engine. The JJ risk engine calculates t-year probabilities of fatal and non-fatal coronary heart disease, fatal and non-fatal stroke, non-cardiovascular mortality, overt nephropathy defined by persistent proteinuria and progression of retinopathy by inputting a covariate vector X and a time point for prediction t (i.e. the formula calculates 5-year probability if t=5) into the formula shown below. 2 Specifically, define X={sex (man=0, woman=1), age, HbA1C, years after diagnosis, BMI<18.5 kg/m (yes=1, no=0), BMI≥25 kg/m2 (yes=1, no=0), systolic blood pressure, non-high-density lipoprotein cholesterol, log-transformed urine albumin-to-creatinine ratio, atrial fibrillation (yes=1, no=0), current smoker (yes=1, no=0), leisure time physical activity (≥3.8METs-h/wk=1, otherwise=0) }. Let βjk be a vector of log hazard ratios for transition from state j to k; the state indexed by j=1…7 represent the initial state, presence of Stage 1 or 4 retinopathy, fatal and non-fatal coronary heart disease, fatal and non-fatal stroke, non-cardiovascular mortality, overt nephropathy defined by persistent proteinuria and progression of retinopathy, respectively. The states j=3…7 were assumed to be absorbing. The estimated hazard ratios for the JJ risk engine, exp(βjk), are provided in Table 1. Let λ0jk(t) be a baseline transition intensity for transition from state j to k. Then, the cause-specific transition intensity for a patient with covariate Xi is written as λijk(t)=λ0jk(t)exp(Xiβjk).
  • Photo Credits

    Photo Credits

    Photo Credits Fig.2.2 Ajinomoto, Inter-Technology Guide, Brochure, undated, page 2/3 (J) Fig. 2.3 The Chemo-Sero-Therapeutic Research Institute, Profile, undated, p. 5 (J IE) Fig.2.4 Chugai Pharmaceuticals Co. Ltd, Fuji Laboratories, Brochure, undated, cover (J) Fig. 2.5 Ciba Geigy International Research Laboratories, Brochure, undated, back cover (J) Fig.2.6 Daicel Chemical Industries, Ltd., Tsukuba Research Center, Innovation for Tommorow, Brochure, October 1989, inside cover (J) Fig. 2.7 Photograph courtesy of Fujisawa Pharmaceuticals Fig. 2.8 The Green Cross Corporation, Green Cross Central Research Laboratories, Brochure, December 1988, p. 3 (J IE) Fig.2.9 Hayashibara Group, Brochure, September 1988, p. 23/24 (E) Fig. 2.10 Hitachi, Hitachi Research Laboratory, Brochure, undated, unpaginated (J) Fig. 2.11 Hoechst, Hoechst in Kawagoe, Brochure, undated, p. 2 (J) Fig. 2.12 Japan Synthetic Rubber, Tsukuba Research Center, Brochure, May 1989, cover (J) Fig. 2.13 Photograph courtesy of Kansai Paint Fig. 2.14 Kao, R&D Activities at Kao, Brochure, undated, p. 2 (E/J) Fig. 2.15 Kirin Biotechnology, Leaflet Collection, undated, unpaginated (E) Fig. 2.16 Komatsu, Research Division, Brochure, January 1990, p. 2 (J/E) Fig. 2.17 Kureha Chemical Industry Co., Ltd., Brochure, May 1989, p. 13 (E) Fig. 2.18 Kyowa, Kyowa Hakko's R&D, Brochure, undated, unpaginated (J/E) Fig. 2.19 Lion Corporation, Annual Report 1988, p. 6 (E). Original photograph courtesy of Lion Co. Fig. 2.20 Meiji Milk Products, Meiji, Brochure, undated, p. 6/7 (E) Fig. 2.21 Mitsubishi Petrochemical Co., Ltd., Research and Development,Brochure, January 1990, p.
  • List of Fellows Selected Through Open Recruitment in Japan

    List of Fellows Selected Through Open Recruitment in Japan

    List of Fellows Selected through Open Recruitment in Japan The following list includes the names of the selected fellows, their host researchers and research themes under the first recruitment of FY 2008-2009 JSPS Postdoctoral Fellowship Program for Foreign Researchers. Under this recruitment, 1057 applications were received, among which 150 fellowships were awarded. Notification of the selection results will be made in writing through the head of the applying institution in the middle of December, 2007. An award letter will be sent to the successful candidates. Unsuccessful applicants (host researchers) will receive a notice of their approximate ranking, and will inform the candidates. Individual requests for selection results are not accepted. Fellow Family Name First Name Middle Name Host Researcher Host Institution Research Theme ABDEL-JAWAD Majed ICHIRO TERASAKI Waseda University Nonlinear thermoelectric effects in strongly-correlated organic conductors AHMMAD Bashir YOSHIHUMI Kagoshima University Development of Solar Cell-Hydrogen KUSUMOTO Production System Using Visible Light-responsive Photocatalysts AHSAN Nagib SETSUKO KOMATSU National Agriculture and Proteomic analysis of greenhouse Food Research gas-responsive proteins in rice and soybean Organization AKHTAR Muhammad Shahbaz YOKO OKI Okayama University From soil to cell and source to sink: P in the soil & strategy to enhance P-bioavailability ALAM Md. Zahangir SEIJI KURIHARA Kumamoto University Synthesis of Photoresponsive Hyperbranched Azopolymers for Photonic Applications
  • Tekken: Dark Resurrection

    Tekken: Dark Resurrection

    Tekken DR PSP Manual 6/30/06 11:23 AM Page 1 MANUAL FRONT COVER Tekken DR PSP Manual 6/30/06 11:23 AM Page 1 For safe use of this product, carefully read the following section of this manual and the Precautions section of the instruction manual supplied with the PSP (PlayStation®Portable) entertainment system before use. Retain both this software manual and the instruction manual for future reference. Health precautions • When operating the unit, play in a well-lit room and keep a safe distance from the screen. • Avoid prolonged use of the system. Take a break of about 15 minutes during every hour of play. • Do not use the system when you are tired or short of sleep. • When using headphones, do not turn the volume up before putting the headphones on. Also, do not listen at loud volume levels for extended periods of time. Stop using the system immediately if you experience any of the following symptoms. If the condition persists, consult a doctor. • Lightheadedness, nausea, or a sensation similar to motion sickness. • Discomfort or pain in the eyes, ears, hands, arms, or any other part of the body. Use and handling precautions • This disc is PSP™ (PlayStation®Portable) format software and is intended for use with the PSP system only. If the disc is used with other devices, damage to the disc or to the device may result. • This disc is compatible for use with the PSP™ system marked with FOR SALE AND USE IN U.S. ONLY. • Depending on the software, a Memory Stick™ Duo or Memory Stick™ PRO Duo (both sold separately) may be required.
  • A Critical Understanding of Japan's Improved Late 20Thcentury

    A Critical Understanding of Japan's Improved Late 20Thcentury

    A Critical Understanding of Japan’s Improved Late 20th Century Relations in Eastern Asia Thesis submitted for the requirements for Doctor of Philosophy, Department of International Relations, London School of Economics and Political Science, September 29, 2003. Revisions completed : February 14, 2005. Jayantha Jayman UMI Number: U6157B9 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Dissertation Publishing UMI U615739 Published by ProQuest LLC 2014. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 ureses f Bntisn Lib^arv o ' Political a n d E c o o ' «rtMt S c ie ,v ’f! \ZC& ABSTRACT Japan’s imperial history and its narrow self-interested post-WW II policies caused much animosity in Eastern Asia, yet its improved relations in the region from the 1980s onwards, even when assessed from a critical perspective, demand scholarly attention. This dissertation finds improved relations a result of Japan legitimating its regional hegemony. The critical theories of Gramsci (1937) and Habermas (1976) applied within intemtional relations suggest legitimation of hegemonic power at the international level only occurs when providing ‘global public goods’—defined metaphorically with the UNDP’s modification of Kindleberger’s (1986) work—such that post colonial states achieve rapid economic development to close the rich-poor gap as understood by Strange (1950).